US Patent 8986697 Antibodies for the treatment of
Patent 8986697 was granted and assigned to Progenics Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8986697 Antibodies for the treatment of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.